Reportlinker.com announces that a new market research report is available in its catalogue.
Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players)
http://www.reportlinker.com/p0116162/Pharmacodiagnostics-and-Personalized-Medicine-2009-(Markets-Challenges-Forecasts-and-Key-Players).html
Pharmacodiagnostics are considered the pathway to what has been termed "personalized medicine," the use of molecular analysis to achieve optimum medical outcomes in the management of a patient's disease or predisposition to disease. As such, personalized medicine promises to bring about a new standard of healthcare, with the possibility to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this undertaking? What are the likely challenges for pharma companies and IVD companies? Will the current economy impact this emerging market?
This report, Pharmacodiagnostics and Personalized Medicine (Markets, Challenges, Forecasts and Key Players) presents a realistic look at the promise and pitfalls of personalized medicine, with important data useful for business planning and marketing efforts, including: